Is Medico Remedies Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Medico Remedies Ltd (MEDICO.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Medico Remedies Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medico Remedies Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Medico Remedies Ltd?

Muslim investors may consider investing in Medico Remedies Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Medico Remedies Ltd classified as HALAL?

Musaffa determines the Shariah status of Medico Remedies Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Medico Remedies Ltd updated?

The Shariah compliance status of Medico Remedies Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Medico Remedies Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Medico Remedies Ltd?

You can check the latest Shariah compliance status of Medico Remedies Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MEDICO.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 11, 2026

Report Source: 2026 3rd Quarter Report

Medico Remedies Ltd. Stock Analysis MEDICO.NS

India Health Care Nano Cap Report: Q3, 2026

Medico Remedies Ltd. engages in the manufacture, supply, and exportation of pharmaceutical drugs. The firm is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The firm also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.

Key Statistics of Medico Remedies Ltd (MEDICO.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹42.42₹45.55

Today's Open

₹43.20

Volume

209.72K

P/E Ratio (TTM)

35.80

52 Week Range

₹30.22₹58.99

Market Cap

3.52B

Avg. Volume

216.71K

Dividend Yield

Financial Metrics & Statements of Medico Remedies Ltd (MEDICO.NS)

FAQ's for Medico Remedies Ltd (MEDICO.NS)

According to Musaffa’s Shariah screening methodology, Medico Remedies Ltd (MEDICO.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.